Catalyst Biosciences Reports Fourth Quarter and Full-Year 2017 Operating & Financial Results Pharmaceutical Investing
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2017 Financial Results Pharmaceutical Investing
Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis Pharmaceutical Investing
Alimera Sciences Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Corium Announces Proposed Offering of $100 Million of Convertible Senior Notes Pharmaceutical Investing
Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Life Science Investing
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2017 Financial Results Pharmaceutical Investing
Sorrento Therapeutics Subsidiary, Scilex, Receives US FDA Approval for Non-Opioid ZTlido Pharmaceutical Investing
Foamix Reports Fiscal Year 2017 Financial Results and Provides Corporate Update Pharmaceutical Investing
ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update Pharmaceutical Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
